Drug intelligence / Profile preview

Bai-re-si Pills

Development stage: Unknown
Lead developer: Humanwell Healthcare
Modality: Small Molecules
Administration: Oral

Overview

Bai-re-si Pills is an oral modernized Uighur medicine formulation developed by Beijing Renfu Junwei Pharmaceutical Technology Development, a subsidiary of Humanwell Healthcare, for the treatment of stable vitiligo. The drug is classified as a Category 1 innovative drug in China, representing a standardized pharmaceutical preparation of traditional Uighur medicine (TUM). It is derived from the plant *Vernonia anthelmintica* (L.) Willd., which has a long history of use in Uighur medicine for skin depigmentation disorders. The mechanism of action involves stimulating melanocyte proliferation and increasing tyrosinase activity, which facilitates melanin synthesis and promotes the repigmentation of vitiliginous skin patches.

Brand names: Bai-re-si Pills
Other names: Bai-re-siBairesi Pills白热斯丸

Targets

TYR (Tyrosinase)TYRP1 (Tyrosinase-related protein 1)

Beyond the preview

Go deeper on Bai-re-si Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bai-re-si Pills.

Explore the full profile